Interim R Interim Repor eport Q1 2018 Q1 2018 Ma Magn gnus us - - PowerPoint PPT Presentation

▶
interim r interim repor eport
SMART_READER_LITE
LIVE PREVIEW

Interim R Interim Repor eport Q1 2018 Q1 2018 Ma Magn gnus us - - PowerPoint PPT Presentation

Nov 10, 2023 196 likes •365 views

Interim R Interim Repor eport Q1 2018 Q1 2018 Ma Magn gnus us Gr Grot oth, , Pr Pres esiden ident t an and d CEO CEO This presentation may contain forward-looking statements. Such statements are based on our current expectations

slide-1
SLIDE 1

Interim R Interim Repor eport Q1 2018 Q1 2018

Ma Magn gnus us Gr Grot

  • th,

, Pr Pres esiden ident t an and d CEO CEO

slide-2
SLIDE 2

Interim Report Q1 2018 April 27, 2018 2

This presentation may contain forward-looking

  • statements. Such statements are based on our current

expectations and are subject to certain risks and uncertainties that could negatively affect our business. Please read our most recent annual and sustainability report for a better understanding of these risks and uncertainties.

slide-3
SLIDE 3

Summar Summary Q1 2018 Q1 2018

▪ Organic net sales1) increased 3.4% ▪ Adjusted EBITA-margin2) decreased 40bp due to significantly higher raw material costs ▪ Price increases achieved in Consumer Tissue in Europe that have not yet impacted earnings ▪ Good contribution from efficiency improvements ▪ Investments and further restructuring measures following Tissue Roadmap ▪ BSN medical integration and synergies progressing according to plan ▪ Four innovations launched under the brands Jobst, Leukoplast, Lotus and Tork

Interim Report Q1 2018 April 27, 2018 3

1)

Net sales which excludes exchange rate effects, acquisitions and divestments

2)

Excluding items affecting comparability

Q1 2018 vs Q1 2017

slide-4
SLIDE 4

Financial Summar Financial Summary

Q1 2018 vs Q1 2017

April 27, 2018 Interim Report Q1 2018 4

1)

Net sales which excludes exchange rate effects, acquisitions and divestments

2)

Excluding items affecting comparability

3)

Excluding items affecting comparability, currency translation effects and acquisitions

Or Organic Ne Net t Sales1)

1)

Adjust Adjusted EBIT BITA2)

2)

Ne Net t Sales

SEK SEK 28 28,020 ,020m +1 +10.9% 0.9% SEK SEK 3,11 3,119m 9m +7% +7%

x% x%

+3 +3.4% .4%

Adjust Adjusted EBIT BITA A Mar Margin2)

2)

11 11.1% .1%

  • 40bp

40bp

  • 5%

5%3)

3)

Or Organic Adjust Adjusted EBIT BITA Op Operating ting Cash Cash Flow

SEK SEK 2,38 2,386m 6m

slide-5
SLIDE 5

Financial Financial Summar Summary

Q1 2018

April 27, 2018 Interim Report Q1 2018 5

1) Excluding items affecting comparability 2) Excluding items affecting comparability and amortization of acquisition related intangible assets

SEK K x Adjust Adjusted ROCE OCE1)

11 11.9% .9%

Adjust Adjusted ROE OE1) EPS EPS SEK K x

2.08 2.08 SEK SEK

Ad Adjus juste ted EPS EPS2)

2.61 2.61 SEK SEK 15 15.3% .3%

slide-6
SLIDE 6

Net Net Sale Sales

Q1 2018 vs Q1 2017

April 27, 2018 Interim Report Q1 2018 6

Net Sales Q1 2017 Price/Mix Volume Acquisitions Currency Net Sales Q1 2018 +0.9%

  • 0.6%

+2.5% +8.1% +10.9% Organic Net Sales +3.4% SEK 25,268m SEK 28,020m

slide-7
SLIDE 7

Adjust Adjusted ed EBIT EBITA1)

1)

Q1 2018 vs Q1 2017

April 27, 2018 Interim Report Q1 2018 7

1)

Excluding items affecting comparability

Organic Adjusted EBITA1) -5%

Adjusted EBITA Q1 2017 Price/Mix Volume Raw Material Energy Cost Savings Other Acquisitions Currency Adjusted EBITA Q1 2018

SEK 2,917m

+7%

SEK +129m SEK +250m SEK -755m SEK +40m SEK +232m SEK -35m SEK +353m SEK -12m SEK 3,119m

1) 1)

slide-8
SLIDE 8

Raw Raw Ma Material terial De Development elopment

April 27, 2018 Interim Report Q1 2018 8

50 75 100 125 150

Jan-16 Mar-16 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 Jul-17 Sep-17 Nov-17 Jan-18 Mar-18

Market Pulp in USD, China

Index 100 = January 2016

NBSK (China) EUCA (China)

1) Index based in local currencies

50 75 100 125 150

Jan-16 Mar-16 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 Jul-17 Sep-17 Nov-17 Jan-18 Mar-18

Market Pulp in USD, Europe

Index 100 = January 2016

Fluff (EU) NBSK (EU) EUCA (EU)

50 75 100 125 150

Jan-16 Mar-16 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 Jul-17 Sep-17 Nov-17 Jan-18 Mar-18

Paper for Recycling1)

Index 100 = January 2016

SOP US SOP EU

slide-9
SLIDE 9

Inno Innova vations f tions for

  • r People

eople and Na and Natur ture

▪ Four innovations launched under the brands Jobst, Leukoplast, Lotus and Tork

Q1 2018

April 27, 2018 Interim Report Q1 2018 9

slide-10
SLIDE 10

Per ersonal Car sonal Care

▪ Organic net sales increased 4.5% ─ Volume +5.9% and price/mix -1.4% ─ All product segments contributed ▪ Adjusted EBITA margin1) 14.2% ▪ BSN medical integration and synergies progressing according to plan ─ Higher adjusted EBITA margin1) ▪ Significant raw material headwinds ▪ Good contribution from cost savings ▪ Continued competitive pressure

Q1 2018 vs Q1 2017

Interim Report Q1 2018 April 27, 2018 10

1)

Excluding items affecting comparability

SEK 10,785m SEK 8,455m Q1 2017 Q1 2018 Q1 2017 Q1 2018 Q1 2017 Q1 2018 SEK 1,532m SEK 1,228m

Net Sales Adjusted EBITA1) Adjusted EBITA Margin1)

+25% +27.6%

  • 30bp

14.5% 14.2% +4.5% Total Mature Markets Incontinence Products

By Region By Product Segment

Emerging Markets +4.5% +5.2% +1.1% +7.1% Baby Care Feminine Care % of Personal Care Net Sales: 63% 37% 43% 21% 17% 19% 0.1%1) +4.5% Medical Solutions

Organic Net Sales By Region

slide-11
SLIDE 11

Consu Consumer mer Tissue Tissue

Q1 2018 vs Q1 2017

Interim Report Q1 2018 April 27, 2018 11

1)

Excluding items affecting comparability

SEK 11,003m SEK 10,473m SEK 966m SEK 1,151m

Net Sales Adjusted EBITA1) Adjusted EBITA Margin1)

  • 16%

+5.1%

  • 220bp

11.0% 8.8% Q1 2017 Q1 2018 Q1 2017 Q1 2018 Q1 2017 Q1 2018 +3.9% Total Mature Markets

Organic Net Sales By Region

Emerging Markets +1.5% % of Consumer Tissue Net Sales: 57% 43% +6.4%

▪ Organic net sales increased 3.9% ─ Volume +1.9% and price/mix +2.0% ▪ Adjusted EBITA margin1) 8.8% ▪ Higher prices in Asia and Latin America ▪ Higher sales in Europe due to higher volumes and better mix but lower prices ▪ Price increases achieved in Europe that have not yet impacted earnings ▪ Significant raw material headwinds ▪ Good contribution from cost savings ▪ Further restructuring measures following Tissue Roadmap

slide-12
SLIDE 12

Pr Prof

  • fessional

essional Hygiene Hygiene

Q1 2018 vs Q1 2017

Interim Report Q1 2018 April 27, 2018 12

▪ Organic net sales increased 0.4% ─ Volume -1.8% and price/mix +2.2% ▪ Adjusted EBITA margin1) of 12.4% ▪ Lower volumes in North America ▪ Higher prices in North America and better mix in both North America and Western Europe ▪ Raw material headwinds ▪ Good contribution from cost savings ▪ Investments and further restructuring measures following Tissue Roadmap

1)

Excluding items affecting comparability

Q1 2017 Q1 2018

SEK 6,218m SEK 6,383m

Net Sales Adjusted EBITA1) Adjusted EBITA Margin1)

+7%

  • 2.6%

+110bp 11.3% 12.4% SEK 720m SEK 772m Q1 2017 Q1 2018 Q1 2017 Q1 2018 Q1 2017 Q1 2018 +0.4%

  • 2.1%

% of Professional Hygiene Net Sales: +11.5% Total Mature Markets Emerging Markets 81% 19%

Organic Net Sales By Region

slide-13
SLIDE 13

Summar Summary Q1 2018 Q1 2018

▪ Organic net sales1) increased 3.4% ▪ Adjusted EBITA-margin2) decreased 40bp due to significantly higher raw material costs ▪ Price increases achieved in Consumer Tissue in Europe that have not yet impacted earnings ▪ Good contribution from efficiency improvements ▪ Investments and further restructuring measures following Tissue Roadmap ▪ BSN medical integration and synergies progressing according to plan ▪ Four innovations launched under the brands Jobst, Leukoplast, Lotus and Tork

Interim Report Q1 2018 April 27, 2018 13

1)

Net sales which excludes exchange rate effects, acquisitions and divestments

2)

Excluding items affecting comparability

Q1 2018 vs Q1 2017

slide-14
SLIDE 14

Q&A Q&A

slide-15
SLIDE 15